Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease

Hamzah Abu-Sbeih, David M. Faleck, Biagio Ricciuti, Robin B. Mendelsohn, Abdul R. Naqash, Justine V. Cohen, MacLean C. Sellers, Aanika Balaji, Guy Ben-Betzalel, Ibraheim Hajir, Jiajia Zhang, Mark M. Awad, Giulia C. Leonardi, Douglas B. Johnson, David J. Pinato, Dwight H. Owen, Sarah A. Weiss, Giuseppe Lamberti, Mark P. Lythgoe, Lisa ManuzziChristina Arnold, Wei Qiao, Jarushka Naidoo, Gal Markel, Nick Powell, Sai Ching J. Yeung, Elad Sharon, Michael Dougan, Yinghong Wang

Research output: Contribution to journal › Article › peer-review

132 Scopus citations

Fingerprint

Dive into the research topics of 'Immune checkpoint inhibitor therapy in patients with preexisting inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences